| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |